Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK122127-01, 5R01DK104344-04, F32DK109620)
Thrasher Research Fund
Nutrition Obesity Research Center at Harvard University
Received: 14 February 2020
Accepted: 10 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Written informed consent was obtained from the parents of infants included in the study according to the standards outlined and approved by the Partners Human Research Committee Institutional Review Board.
: AF is a stockholder at Alba Therapeutics, serves as a consultant for Inova Diagnostics and Innovate Biopharmaceuticals, is an advisory board member for Axial Biotherapeutics and Ubiome, and has a speaker agreement with Mead Johnson Nutrition. MML serves as a consultant to HealthMode and Anokion, has a speaker agreement with Takeda Pharmaceuticals, and performs sponsored research with Glutenostics LLC. HK is a former employee, BF is a current employee, PS is a consultant, and RRC and NAH are stockholders at CosmosID Inc. Other authors have declared no competing interests exist.